BOT:ASX
Botanix Pharmaceuticals Ltd
၀.၀၁၇ A$
၀.၀၀%
(၀.၀၀) 1D
အောက် ၇, GMT+၁၁ ၁၆:၁၀:၀၇ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Mkt. cap
၃.၉၈ ကုဋေ
Avg. vol.
၅.၉၂ သန်း
Volume
၀.၀၀
52-wk high
၀.၁၇ A$
52-wk low
၀.၀၂ A$
EPS
-၀.၀၃ A$
Shares outstanding
၂၇၆.၁၅ ဋေ
No. of employees
၁၁
Mkt. cap
၃.၉၈ ကုဋေ
Avg. vol.
၅.၉၂ သန်း
Volume
၀.၀၀
52-wk high
၀.၁၇ A$
52-wk low
၀.၀၂ A$
EPS
-၀.၀၃ A$
Shares outstanding
၂၇၆.၁၅ ဋေ
No. of employees
၁၁
News stories
From web sources and news partners
24/7 Wall St.
·
ပြီးခဲ့သည့် ၄၆ မိနစ်
JEPQ Trailed the Nasdaq-100 by $17,970 on $300,000 Over One Year. The Covered Calls Are Why
TradingView
·
ပြီးခဲ့သည့် ၁ နာရီ
Winklevoss Zcash ETF Filing Brings Privacy Coin Exposure To Nasdaq
The Motley Fool
·
ပြီးခဲ့သည့် ၁ နာရီ
The S&P 500 Just Reached a New Record. Here’s What History Says About Buying Stocks Now.
Yahoo Finance
·
ပြီးခဲ့သည့် ၇ နာရီ
These 7 major S&P 500 stocks need to rally at least 200% to reclaim their peaks
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd